Pencil Biosciences
- Biotech or pharma, therapeutic R&D
Pencil Biosciences is developing a fully synthetic, non-CRISPR gene editing platform technology for utilisation in genomic medicine, cell and gene therapies and bioproduction
June 16-19, 2025
Boston Convention & Exhibition Center
Pencil Biosciences is developing a fully synthetic, non-CRISPR gene editing platform technology for utilisation in genomic medicine, cell and gene therapies and bioproduction